SRNEQ - SORRENTO THERAPEUTICS INC
This page shows which of the focused investors we track hold SRNEQ and how their positions changed, so you can see how much conviction the group has in the stock.
In Q2 2020 it was held by 2 managers with an aggregate reported value of $945K, which is 0.00% of the combined portfolio.
As of Q2 2020, 2 tracked institutional managers held SRNEQ (SORRENTO THERAPEUTICS INC) with an aggregate reported value of $945K — 0.00% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades SRNEQ — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q2 2020
- Ticker
- SRNEQ
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | Howard Marks - Oaktree Capital Management | 0.01% | New | 100,500 | $631K |
| 2 | David Katz - Matrix Asset Advisors | 0.06% | - | 50,000 | $314K |
Loading holder history for SRNEQ…